<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="53573">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01813331</url>
  </required_header>
  <id_info>
    <org_study_id>161/12</org_study_id>
    <nct_id>NCT01813331</nct_id>
  </id_info>
  <brief_title>ALERT-HF: Adherence to Guidelines in the Treatment of Patients With Chronic Heart Failure</brief_title>
  <acronym>ALERT-HF</acronym>
  <official_title>ALERT-HF:Adherence to Guidelines in the Treatment of Patients With Chronic Heart Failure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Federico II University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Federico II University</source>
  <oversight_info>
    <authority>Italy: Federico II University</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      ALERT-HF is an observational study aimed to evaluate the diagnostic criteria adopted and the
      adherence to the current therapeutic guidelines in a large series of patients affected with
      chronic heart failure. Secondary objective is to evaluate the prevalence of chronic heart
      failure among all the patients referring to the ambulatory cardiologists of the healthcare
      district.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2012</start_date>
  <completion_date type="Actual">February 2013</completion_date>
  <primary_completion_date type="Actual">January 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational [Patient Registry]</study_type>
  <study_design>Observational Model: Case-Only, Time Perspective: Cross-Sectional</study_design>
  <target_duration>3 Months</target_duration>
  <primary_outcome>
    <measure>Number of patients treated with each of the following indicators of adherence to the current therapeutic guidelines:-ACEI -ARB -beta blockers -loop diuretics -aldosterone antagonists -digoxin -anticoagulant therapy  - implantation of cardiac devices</measure>
    <time_frame>first physical examination and clinical evaluation performed during a 3 months period, from November 2012 to January 2013</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>evaluate the prevalence of chronic heart failure among all the patients referring to the ambulatory cardiologists of the healthcare district</measure>
    <time_frame>first evaluation</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">660</enrollment>
  <condition>Chronic Heart Failure</condition>
  <arm_group>
    <arm_group_label>Chronic Heart Failure Patients</arm_group_label>
    <description>Chronic Heart Failure  patients older than 65 years, which accept to participate to the study and give their informed written consent and consecutively refer to the A.R.C.A Campania Cardiologists in the pertaining healthcare districts.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Chronic Heart Failure patients older than 65 years, consecutively referred to the A.R.C.A
        Campania Cardiologists in the pertaining healthcare districts
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of Heart Failure

          -  Signature of informed consent

          -  Age older than 65 years

        Exclusion Criteria:

          -  indication for cardiac surgery or cardiac surgery by less than 3 months

          -  age less than 65 years

          -  inability to perform periodic checks

          -  presence of malignant neoplasms and other severe diseases.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>ARCA Campania healthcare ambulatories</name>
      <address>
        <city>Naples</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>March 2013</verification_date>
  <lastchanged_date>March 13, 2013</lastchanged_date>
  <firstreceived_date>March 7, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Federico II University</investigator_affiliation>
    <investigator_full_name>Oliviero Ugo</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
